XML 60 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
Segment
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Cash, Cash Equivalents and Restricted Cash [Abstract]        
Cash and cash equivalents $ 297,098 $ 185,383    
Restricted cash 1,568 1,525    
Total 298,666 186,908 $ 112,791 $ 18,349
Government Grants [Abstract]        
Receivable of offset grants against expenses 3,600 1,200 0  
Investments [Abstract]        
Realized gains (losses) on investment 0 0 0  
Unrealized gain on investments $ (62) 147 (127)  
Goodwill [Abstract]        
Number of operating segment | Segment 1      
Number of reporting unit | Segment 1      
Goodwill impairment $ 0 0 0  
Impairment of Long-Lived Assets [Abstract]        
Impairment of long-lived assets 0 0 0  
NYC Biotechnology Tax Credit Program [Abstract]        
Research and development incentive income $ 0 $ 300 $ 200  
Internal use Software [Member]        
Property and Equipment [Abstract]        
Estimated useful lives 6 years      
Minimum [Member]        
Property and Equipment [Abstract]        
Estimated useful lives 3 years      
Maximum [Member]        
Property and Equipment [Abstract]        
Estimated useful lives 15 years